Q2 2024 VolitionRX Ltd Earnings Call Transcript

Aug 15, 2024 / 12:30PM GMT
Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the VolitionRx Limited second quarter 2024 earnings conference call. (Operator Instructions) This conference is being recorded today, August 15, 2024. I would now like to turn the conference call over to Louise Batchelor, Group Chief Marketing and Communications Officer. Please go ahead.

Louise Batchelor – VolitionRX Ltd – Group Chief Marketing and Communications Officer

Thank you, and welcome, everyone, to today’s earnings conference call for VolitionRx Limited. Before we begin, I’d like to remind everyone that some of the information discussed on this conference call will include forward-looking statements covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

These statements are based on our beliefs as well as assumptions we have used upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions.

Actual